Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

NACompletedINTERVENTIONAL
Enrollment

1,638

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Breast Cancer
Interventions
DEVICE

Molecular Breast Imaging

Molecular breast imaging is a new nuclear medicine technique for imaging the breast. It uses small field of view semiconductor-based gamma cameras that use Cadmium Zinc Telluride detectors. These have superior spatial and energy resolution to conventional sodium iodide detectors.

DEVICE

Conventional Mammography

Mammography is the process of using low-energy X-rays (usually around 30 kVp) to examine the human breast and is used as a diagnostic and a screening tool.

DRUG

Technetium (99mTc) sestamibi

Technetium (99mTc) sestamibi is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile (MIBI) ligands.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

Mayo Clinic

OTHER

NCT01925170 - Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts | Biotech Hunter | Biotech Hunter